Latest Market News

Ryder Capital Limited reports a robust $13.02 million total comprehensive income for 1H FY25, driving a 12.5% increase in its fully franked interim dividend to 4.5 cents per share.

Ryder Capital Limited has announced a fully franked ordinary dividend of AUD 0.045 per share for the half-year ending December 2024, reflecting steady returns to shareholders.

Ryder Capital Limited has reported a striking 312% increase in total comprehensive income for the half-year ended December 31, 2024, alongside a 12.5% hike in its fully franked interim dividend, underscoring robust portfolio performance amid market uncertainties.

Critica Limited has announced a landmark maiden Mineral Resource Estimate for its Jupiter Project, establishing it as Australia's largest and highest-grade clay-hosted rare earth deposit with significant strategic potential.

Light & Wonder, Inc. has amended its credit agreement to increase its revolving credit facility from $750 million to $1 billion, extend the maturity to 2030, and reduce interest margins based on leverage tests, enhancing its financial flexibility.

Citigroup Global Markets Australia announces a fully franked $1.70 dividend for JBH CitiFirst Instalment MINIs, aligning with JBH Ordinary shares’ record date and ex-dividend schedule.

Memphasys has completed the final patient visit in its Felix™ clinical trial, with data lock expected within two weeks and preliminary results slated for early March 2025. This milestone paves the way for CE Mark submission and imminent commercialisation in Europe.

Elixir Energy Limited's shares have been suspended from trading pending a significant announcement about expanding its Taroom Trough position, signaling potential strategic growth in its energy assets.

Arizona Lithium Limited is set to deploy Koch Technology Solutions’ first commercial-scale Li-Pro DLE unit at its Prairie Project, marking a pivotal advancement in lithium extraction from oilfield brines.

Clarity Pharmaceuticals has expanded its breast cancer pipeline by introducing 64/67Cu-SAR-trastuzumab, supported by promising pre-clinical data and a new supply agreement for trastuzumab, aiming to address the unmet needs in HER2-positive breast cancer treatment.

China’s new export restrictions on molybdenum have shifted global supply dynamics, positioning EV Resources’ Parag copper-molybdenum project in Peru as a strategic alternative supplier to the USA and Americas. With strong drilling results confirming high-grade molybdenum by-product, EV Resources is advancing plans amid growing demand.

Connected Minerals Ltd has pinpointed priority drill targets at its newly granted Swakopmund Uranium Project in Namibia following a successful HLEM geophysical survey. The company is advancing plans for an initial drilling campaign set to begin in Q2 2025.